Clinical Trial Update: Treatment Selection According to Skin Reaction to Cetuximab [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial explores whether skin reaction to cetuximab can guide treatment selection in patients with head and neck cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• ERBITUX (cetuximab)

Snippet

Sponsor: Institute of Oncology Ljubljana | Conditions: Head and Neck Cancer | Phase 2 | Status: UNKNOWN